Sammy Farah, Turnstone Biologics CEO
July 17, 2023 09:58 AM EDT
Financing
Startups

Turn­stone charts $75M IPO for TIL cell ther­a­pies in drum­roll of biotech IPOs this month

Kyle LaHucik

Senior Reporter

Turn­stone Bi­o­log­ics plans to list on the Nas­daq in a $75 mil­lion raise short­ly af­ter a trio of biotechs — Apogee Ther­a­peu­tics, Sagimet Bio­sciences and 60 …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

FDA ap­proves sub­cu­ta­neous ver­sion of Bris­tol My­er­s' Op­di­vo

BioN­Tech set­tles with NIH, UPenn in Covid vac­cine dis­putes and will pay roy­al­ties

J&J part­ners on STAT6; As­traZeneca, Dai­ichi with­draw lung can­cer drug EMA app

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

A service from the Financial Times